1. Home
  2. POAI vs MITQ Comparison

POAI vs MITQ Comparison

Compare POAI & MITQ Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • POAI
  • MITQ
  • Stock Information
  • Founded
  • POAI 2002
  • MITQ N/A
  • Country
  • POAI United States
  • MITQ United States
  • Employees
  • POAI N/A
  • MITQ N/A
  • Industry
  • POAI Industrial Specialties
  • MITQ Telecommunications Equipment
  • Sector
  • POAI Health Care
  • MITQ Telecommunications
  • Exchange
  • POAI Nasdaq
  • MITQ Nasdaq
  • Market Cap
  • POAI 8.9M
  • MITQ 7.3M
  • IPO Year
  • POAI N/A
  • MITQ 2021
  • Fundamental
  • Price
  • POAI $1.09
  • MITQ $0.57
  • Analyst Decision
  • POAI Hold
  • MITQ
  • Analyst Count
  • POAI 1
  • MITQ 0
  • Target Price
  • POAI N/A
  • MITQ N/A
  • AVG Volume (30 Days)
  • POAI 359.2K
  • MITQ 343.7K
  • Earning Date
  • POAI 05-13-2025
  • MITQ 05-14-2025
  • Dividend Yield
  • POAI N/A
  • MITQ N/A
  • EPS Growth
  • POAI N/A
  • MITQ N/A
  • EPS
  • POAI N/A
  • MITQ N/A
  • Revenue
  • POAI $1,623,817.00
  • MITQ $18,932,000.00
  • Revenue This Year
  • POAI $486.27
  • MITQ N/A
  • Revenue Next Year
  • POAI $65.50
  • MITQ N/A
  • P/E Ratio
  • POAI N/A
  • MITQ N/A
  • Revenue Growth
  • POAI N/A
  • MITQ N/A
  • 52 Week Low
  • POAI $0.55
  • MITQ $0.42
  • 52 Week High
  • POAI $3.06
  • MITQ $1.55
  • Technical
  • Relative Strength Index (RSI)
  • POAI 48.65
  • MITQ 45.85
  • Support Level
  • POAI $0.85
  • MITQ $0.52
  • Resistance Level
  • POAI $1.44
  • MITQ $0.69
  • Average True Range (ATR)
  • POAI 0.12
  • MITQ 0.09
  • MACD
  • POAI -0.01
  • MITQ -0.01
  • Stochastic Oscillator
  • POAI 40.68
  • MITQ 16.38

About POAI Predictive Oncology Inc.

Predictive Oncology Inc functions in the healthcare domain. The firm's reportable segments are Pittsburgh segment that provides services which include the application of AI using its proprietary biobank of 150,000+ tumor samples. It also creates proprietary 3D culture models used in drug development; Birmingham segment that provides contract services and research focused on solubility improvements, stability studies, and protein production; and Eagan segment that produces the FDA-cleared STREAMWAY System and associated products for automated medical fluid waste management and patient-to-drain medical fluid disposal. It derives maximum revenue from Eagan Segment.

About MITQ Moving iMage Technologies Inc.

Moving iMage Technologies Inc is engaged in providing designed equipment as well as other off the shelf cinema products needed for contemporary cinema requirements. It offers technical, design and consulting services such as custom engineering, systems design, integration and installation and digital technology, as well as software solutions for operations enhancement and theatre management.

Share on Social Networks: